Genetic polymorphisms of CYP2D6 increase the risk for recurrence of breast cancer in patients receiving tamoxifen as an adjuvant therapy - Concepedia

Concepedia

Publication | Closed Access

Genetic polymorphisms of CYP2D6 increase the risk for recurrence of breast cancer in patients receiving tamoxifen as an adjuvant therapy

53

Citations

28

References

2012

Year

Solai Elango Damodaran, Suresh Chandra Pradhan, Gurusamy Umamaheswaran, Kadambari Dharanipragada, K. Sathyanarayana Reddy, Chandrasekaran Adithan

Cancer Chemotherapy and Pharmacology

Breast OncologyCancer RiskGenetic PolymorphismsMedicinePathologyBreast CancerCancer GeneticsAdjuvant TherapyOncologyRadiation Oncology

References

	Year	Citations

Page 1